期刊文献+

前列腺酸性磷酸酶在非前列腺腺癌中的表达 被引量:5

Expression of prostatic acid phosphatase in non-prostate adenocarcinomas
在线阅读 下载PDF
导出
摘要 目的:探讨前列腺相关抗原-前列腺酸性磷酸酶(PAP)在非前列腺癌中的表达水平.方法:分别用RT-PCR方法和Western Blot方法检测多种腺癌细胞系中PAP mRNA和PAP蛋白的表达水平;用免疫组织化学方法检测多种腺癌肿瘤组织中的PAP蛋白的表达水平.结果:3种结肠癌细胞(colo201,colo205和colo320)、3种胃癌细胞(MKN-7,MKN-28和MKN-45)和7种乳腺癌细胞(OCUB-F,OCUB-M,R-27,MCF-7,CRL-1500,YMB-1-E和MDA-MB-231)表达PAP mRNA和PAP蛋白,结肠癌、胃癌和乳腺癌肿瘤组织中PAP呈阳性表达.在检测的5种肾细胞癌细胞和肾细胞癌组织中均未发现有PAP的表达.结论:PAP是结肠癌、胃癌和乳腺癌的新靶点. AIM: To study the expression of prostatic acid phosphatase (PAP) , a prostate-related antigen, in non-prostate cancer cells or tissues. METHODS: A variety of adenocareinoma cell lines were examined for their PAP expression at the mRNA and protein levels by RT-PCR and Western Blot analysis, respectively. The PAP expression in cancer tissues was also examined by immunohistoehemieal staining. RESULTS: Three kinds of colon cancer cells (colo 201, colo 205 and colo 320 ) , 3 kinds of gastric cancer cells ( MKN-7, MKN-28 and MKN-45 ), and 7 kinds of breast cancer cell lines ( OCUB-F, OCUB-M, R- 27, MCF-7, CRL-1500, YMB-1-E and MDA-MB-231 ) as well as cancer tissues were found to be positive for PAP at both the mRNA and protein levels. But is was not found in 5 kinds of kidney cancer cells or tissues. CONCLUSION: PAP is a new target of non-prostate adenocarcinomas, including colon, breast and gastric cancers.
出处 《第四军医大学学报》 北大核心 2007年第19期1775-1777,共3页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30600743)
关键词 酸性磷酸酶 前列腺 腺癌 acid phosphatase prostate adenocarcinoma
  • 相关文献

参考文献18

  • 1Gutman AB, Gutman EB. An "acid" phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland [J]. JClinInvest, 1938,17(4):473-478.
  • 2Danoli M, Wallner K, True L, et al. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for higher risk prostate carcinoma: Influence of prostatic acid phosphatase [J]. Cancer,2003,97(4):979-983.
  • 3Burch PA, Croghan GA, Gastineau DA, et al. Immunotherapy targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A Phase 2 trial [ J ]. Prostate, 2004,60( 3 ) : 197 - 204.
  • 4Solin T, Kontturi M, Pohlmann R, et al. Gene expression and prostate specificity of human prostatic acid phosphatase (PAP) : Evaluation by RNA blot analyses [J]. Biochim Biophys Acta, 1990, 1048(1) : 72-77.
  • 5Lam KW, Li CY, Yam LT, et al. Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody [J]. Prostate, 1989, 5(1) :13-21.
  • 6Tepper SL, Jagirdar J, Heath D, et al. Homology between the female paraurethral (Skene's) glands and the prostate. Immunohistochemical demonstration [ J ]. Arch Pathol Lab Med, 1984, 108 (5) : 423 - 425.
  • 7Nowels K, Kent E, Rinsho K, et al. Prostate specific antigen and acid phophatase-reactive cells in cystitis cystica and glandularis [J]. Arch Pathol Lab Med, 1988,112 (7) :734 - 737.
  • 8Jobsis AC, De Vries GP, Meijer AE, et al. The immunohistochemical detection of prostatic acid phosphatase: Its possibilities and limitations in tumor histochemistry [ J ]. Histochem J, 1981 (6), 13 : 961 - 973.
  • 9Epstein JI, Kuhajda FP, Lieberman PH. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder [J]. Hum Pathol, 1986, 17(9) :939-942.
  • 10Seki K, Miyakoshi S, Lee GH, et al. Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma [J]. Am J Surg Pathol, 2004,28(10) :1384 - 1388.

同被引文献65

  • 1李亚里,杨怡卓.人乳头瘤病毒亚型检测在宫颈病变分流管理中的意义[J].中国实用妇科与产科杂志,2007,23(7):501-503. 被引量:55
  • 2Beaudenon S, Huibregtse JM. HPV E6, E6AP and cervical cancer. BMC Biochem,2008, 21 (9sl) : $4.
  • 3Bian ML. Brief introduction of the practical guideline about preventing and curing cervical cancer by WHO (2006). Chin J Pract Gynecol Obstet, 2007,23 (7) :557 - 560.
  • 4Kitchener HC, Castle PE, Cox JT. Achievements and limita- tions of cervical cytology screening. Vaccine, 2006,24 ( 3 ) : 63 - 70.
  • 5Arbyn M, Abarca M. Systematic review and meta - analysis. Brussels : Scientific Institute of Public Health ,2006 : 1 - 201.
  • 6Li N, Shi JF, Franceschi S, eta|. Different cervical cancer screening approaches in a Chinese muhicentre study. Br J Cancer, 2009,100:532 - 537.
  • 7Michelle GD, Jose AS, Rita GA, et al. Presence of 20% or more clue cells:An accurate criterion for the diagnosis of bacterial vaginosis in papanieolaou cervical smears. Diagn Cytopatho1,2006,34 (4) : 272 - 276.
  • 8Hovland S, Arbyn M, Lie AK. A comprehensive evaluation of the accuracy of cervical pre - cancer detection methods in a high- risk area in East Congo. Br J Cancer,2010,102:957 - 965.
  • 9Gross SJ, Kinzie G. Cytochemistry of benign and malignant squamous epithelium of the cervix uteri. Obst Gynecol, 1960,15:261 - 279.
  • 10Prabal D, Venkateswaran I, Bhatla N, et al. Cervical acid phosphatase detection:A guide to abnormal cells in cytology smear screening for cervical cancer . J Cytol,2008,25 (1) :1 --5,.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部